Exhibitors Search
Klothxo Labs
Booth no.
H50
|
Exhibition
|
|KOREA LIFE SCIENCE |
|---|---|
|
Country
|
| Korea, South |
|
Address
|
|11 Dangsan-ro 41-gil, Yeongdeungpo-gu, Seoul, Republic of Korea |
|
Tel
|
|+82--- |
|
Exhibits
|
| PF4-driven Regenerative Bio-Signal Platform |
|
Company Type
|
| Pharmaceutical / Drug Development Company , Biotech Venture / Startup |
Exhibitor Information
KlothxoLabs Co., Ltd. is a bio-platform company aiming for the industrialization of PF4 (Platelet Factor 4)-based regenerative bio-signals. Differentiating itself from conventional general-purpose exosome approaches, we are building a platform that secures megakaryocyte (MK)-derived PF4-enriched regenerative signaling and implements it through standardized production processes and quantitative analysis systems.
Beyond simple material production, KlothxoLabs seeks to simultaneously secure the reproducibility and scalability of regenerative efficacy through a platform that integrates production, quantification, standardization, and delivery design.
Beyond simple material production, KlothxoLabs seeks to simultaneously secure the reproducibility and scalability of regenerative efficacy through a platform that integrates production, quantification, standardization, and delivery design.
Exhibit Description
KlothxoLabs is developing platform technology to stably secure and quantify PF4(Platelet Factor 4)-based functional signals derived from megakaryocytes (MK), with the goal of standardizing PF4-based regenerative bio-signals.
The core technology is a PF4 bio-signal standardization platform that includes establishing production conditions for PF4-high phenotype MKs, optimizing Key Differentiation Process Variables (CPPs), constructing PF4 quantification and batch comparability assays, and defining initial QC/IPC items.
Through this, we are ensuring the reproducibility and consistency of PF4-based regenerative signals and establishing a technological foundation scalable to various application formats.
The core technology is a PF4 bio-signal standardization platform that includes establishing production conditions for PF4-high phenotype MKs, optimizing Key Differentiation Process Variables (CPPs), constructing PF4 quantification and batch comparability assays, and defining initial QC/IPC items.
Through this, we are ensuring the reproducibility and consistency of PF4-based regenerative signals and establishing a technological foundation scalable to various application formats.
KYUNGYON EXHIBITION CORP.
